Fibroids: Symptoms and Treatment with Dr. Bradshaw

Fibroid

Do you or someone you know suffer from heavy bleeding, bleeding between periods or pelvic pressure/pain? A possible cause of these symptoms can be a uterine fibroid which is a benign tumor of the uterus. 1 in 5 women may have fibroids in their child bearing years and they usually present around the age of 30. They can continue to grow until menopause and are generally not cancerous, but can cause symptoms.

If a woman is diagnosed with a fibroid or multiple fibroids, the treatment options depend on what symptoms she has and if she wishes to maintain her fertility. Options include medication or surgery. In the past and even today many women end up getting a hysterectomy (removal of a woman’s reproductive organs), or a large incision to remove the fibroids. Most of the time however, neither of these things are necessary. Many women feel they have to have a hysterectomy for their fibroids even when they desire to have children. But this is usually not the case.

Dr. Amber Bradshaw at the Gynecology Specialists of Utah treats uterine fibroids through minimally invasive procedures. Minimally invasive surgery is done through small incisions rather than a large abdominal incision. This approach helps women heal faster and experience less pain while being just as effective as traditional procedures. One example of this type of surgery is Myomectomy; the surgical removal of fibroids leaving the uterus intact for future pregnancies. Myomectomy is a safe and effective way to treat uterine fibroids and this procedure can be done through small abdominal incisions. Dr. Bradshaw is passionate about informing women about minimally invasive surgery and what treatment options are right for them.

To learn more about fibriods, treatment options or to schedule a consultation with Dr. Bradshaw, please visit gynecologyspecialistsutah.com or call (801)476-4200. Her clinic is located on the campus of Ogden Regional Medical Center.

Tags: , , , , , , , , , , , , , , , , , , , ,

Comments are closed.